Secondary acute promyelocytic leukemia: an increasingly common entity

Leuk Lymphoma. 2007 Jan;48(1):190-1. doi: 10.1080/10428190600961736.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / chemically induced*
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced*
  • Radiotherapy / adverse effects
  • Remission Induction
  • Treatment Outcome

Substances

  • Antineoplastic Agents